Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria

Author:

Ebonyi Augustine O1,Okpokwu Jonathan2,Rawizza Holly3ORCID,Chebu Philippe4,Chaplin Beth3,Hamel Donald3,Oguche Stephen1,Agbaji Oche O5,Sagay Atiene S6,Kanki Phyllis J3,Imade Godwin E26ORCID

Affiliation:

1. Department of Paediatrics, University of Jos, Jos University Teaching Hospital , Jos , Nigeria

2. AIDS Prevention Initiative in Nigeria–supported ISO 15189 Laboratory, Jos University Teaching Hospital , Jos , Nigeria

3. Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts , USA

4. APIN Public Health Initiatives, Plot 1551, Apo Resettlement, Apo District , Abuja, FCT , Nigeria

5. Department of Medicine, University of Jos, Jos University Teaching Hospital , Jos , Nigeria

6. Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital , Jos , Nigeria

Abstract

Abstract We determined pretreatment and acquired human immunodeficiency virus (HIV) drug resistance among children with HIV type 1 (HIV-1) in Jos, Nigeria. The majority (71%) of those who failed first-line antiretroviral therapy were on a nevirapine-containing regimen. The prevalence of pretreatment (48%) and acquired (76%) HIV drug resistance mutations was high in our study. Wider access to HIV drug resistance testing after treatment failure is necessary to optimize second-line treatment options among children with HIV in Nigeria.

Funder

STAMINA

Fogarty International Center

Office of the Director

National Institute of Neurological Disorders and Stroke

National Institute of Nursing Research

National Institutes of Health

US Department of Health and Human Services

Health Resources and Services Administration

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3